XML 41 R29.htm IDEA: XBRL DOCUMENT v3.26.1
Schedule of Information by Segment (Details) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting [Line Items]    
Total $ 333,376 $ 91,457
Total research and development costs 333,376 91,457
Cash based compensation 213,434 108,731
Stock-based compensation 82,176 99,738
Patent and licensing legal and filing fees and costs 35,032 56,084
Marketing and public relations 481,900
Accounting and bookkepping services 254,744 41,909
Audit and legal 195,846 134,103
Consulting fees 181,856 29,303
Insurance expense 64,387 64,277
Other costs and expenses, net 144,656 81,338
Total general and administrative costs 1,654,031 615,483
UNITED STATES    
Segment Reporting [Line Items]    
Total 38,972 58,571
Total research and development costs 38,972 58,571
SPAIN    
Segment Reporting [Line Items]    
Total 294,404 32,886
Total research and development costs 294,404 32,886
Clinical And Related Oversight Costs [Member]    
Segment Reporting [Line Items]    
Total 309,794 15,868
Total research and development costs 309,794 15,868
Preclinical Research [Member]    
Segment Reporting [Line Items]    
Total 23,582 42,770
Total research and development costs 23,582 42,770
Regulatory Service Costs [Member]    
Segment Reporting [Line Items]    
Total 32,819
Total research and development costs $ 32,819